March 8, 2017, Lexington, KY: Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization (CDMO), held a special event to introduce the new and expanded manufacturing capabilities at its facilities in Lexington, Kentucky. The inaugural event was attended by Gov. Matt Bevin, Piramal Chairman, Ajay Piramal, and Piramal Pharma Solutions CEO, Vivek Sharma.
LEXINGTON, Ky. – Piramal Pharma Solutions, a provider of sterile drug product development and manufacturing services, has announced plans for a $25 million expansion of its facilities in Lexington, Kentucky.
17th November 2015: Piramal Healthcare UK Ltd., has invested £2.0 million into Scotland to expand its manufacturing base at Grangemouth, to manufacture Antibody Drug Conjugates to global markets. This new investment into Scotland will yield additional revenue of £3-5 mn over 5 years to Piramal Healthcare’s revenues.
21st October, 2015: Piramal Pharma Solutions (PPS), a division of Piramal Enterprises Limited, is pleased to announce that it is the recipient of the ‘API Supplier of the Year’ award for 2015 at Global Generics and Biosimilar Award. This prestigious award, sponsored by Honeywell, Thomson Reuters, Panacea, Pharmawise, Pharmacloud, and Ark Patents, recognizes best business practices, and operational & R&D achievements in Global Generics and Biosimilars.
20th October, 2015: Piramal Enterprises' Pharma Solutions division, a global leader in contract development and manufacturing (CDMO), each year participates at the CPhI Worldwide. This is a convention that brings together the global pharmaceutical community to meet and identify business opportunities.
14th October, 2015: Piramal Enterprises' Pharma Solutions division, a global leader in contract development and manufacturing (CDMO), has delivered its comprehensive review of the injectables market – both sterile and small molecule – for the next 5 years during its CPhI annual report piece.